Swiss Luxury Stock News

Bossard Holding (SWX:BOSN) has scheduled a future finance reshuffle, with long-serving CFO Stephan Zehnder set to hand the reins to incoming executive Andreas Jaeger in early 2027. The incoming CFO announcement has arrived at a time when Bossard Holding’s share price has been strong, with a 1-day share price return of 3.02%, adding to a 90-day gain of 20.10% and a year-to-date share price return of 53.21% at a current level of CHF239.0. Scan how Bossard Holding compares with other industrial...

ABB (SWX:ABBN) is back in focus after two fresh product announcements that push deeper into digital infrastructure. The group is pairing Samsung’s SmartThings Pro with ABB Ability Building Pro, and it is rolling out its AquaMaster+ water management platform in India. The fresh product news comes after a choppy few months for ABB’s shares. The 90 day share price return is down 8.7% and the 30 day move is modestly weaker. However, the year to date share price return of 29.85% and a 1 year total...

Aevis Victoria reported half year 2026 results with sales of CHF 639.1 million, revenue of CHF 547.02 million and net income of CHF 5.42 million, with basic and diluted EPS from continuing operations at CHF 0.06. The small uplift in net profit and earnings per share, alongside largely flat revenue, highlights cost control and business mix rather than pure top line expansion as the near term focus for Aevis Victoria. The focus now turns to how Aevis Victoria's investment narrative...

Galderma Group (SWX:GALD) just reported positive topline data from a 162-patient Restylane Volyme study in China for temple hollowing, meeting its primary endpoint and signaling progress in a key aesthetics market. Against that clinical milestone, Galderma Group’s 1-day share price return of 0.49% to CHF154.05 sits alongside a 30-day share price decline of 8.95% and a 90-day share price decline of 10.75%. The 1-year total shareholder return of 6.33% points to modest longer-term gains and...

Helvetia Baloise Holding reported half year 2026 net income of CHF 68.6 million, with basic and diluted EPS from continuing operations at CHF 0.66, compared with CHF 307.2 million and CHF 5.75 a year earlier. The sharp drop in profitability highlights pressure on Helvetia Baloise Holding's earnings power. This is important for funding growth plans and absorbing insurance claims volatility. We will now see how Helvetia Baloise Holding's investment narrative compares with this steep fall in...

Today is shaping up negative for Jungfraubahn Holding AG ( VTX:JFN ) shareholders, with the analysts delivering a...

R&S Group Holding heads into this earnings season with a bruised chart and a flattering mirror. The share price closed at CHF17.96 on 16 September, with the stock down roughly 10% over the past month and about one third over three months, while the valuation still sits on a P/E of 12.9x against much richer peers. The emotional gap hinges on one thing. Profitability is under more pressure, with trailing net profit margin at 13.4% compared with last year’s 15.3%. That margin squeeze is what the...

Stockholm Office Opening Puts Nordic Expansion In Focus Partners Group Holding (SWX:PGHN) is expanding in the Nordics after opening a Stockholm office that will host dedicated investment professionals and support infrastructure, real estate, and private credit activity across the region. For investors watching Partners Group Holding, the new Stockholm office arrives after a tough run. The share price is down 13.68% over 30 days and the year-to-date share price return has fallen 39.86%, while...

Holcim (SWX:HOLN) has launched the Czech Republic's first calcined clay production line to supply its low-carbon ECOPlanet cement range. The new facility is designed to use calcined clay as a partial clinker substitute, aiming to lower the carbon intensity of cement. Management positions this Czech project as part of Holcim's broader push to scale low-carbon building materials across key European markets. Holcim's launch of a Czech calcined clay line for ECOPlanet cement is worth weighing...

In September 2026, European markets have been navigating a complex landscape marked by rising inflation concerns and increased geopolitical tensions, which have driven oil prices higher and put upward pressure on government bond yields. Amidst these challenges, identifying growth companies with high insider ownership can be appealing to investors seeking resilience and alignment of interests in volatile times.

Cash is suddenly interesting again. Short term rates are higher, central banks are tapping the brakes more carefully, and market swings are pushing more money into brokers, custodians, and money market platforms that sit closest to idle cash. That shift can reshape revenue streams and reprice risk. This article walks through three stocks from our Global Cash and Money-Market Platform Beneficiaries screener that appear well positioned for this new focus on cash. The stocks below are just a...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Amrize (SWX:AMRZ) has been in focus after the board moved Mario Gross into the role of President, Building Envelope, following Jake Gosa’s resignation. This change places leadership of a core division under new oversight. That leadership reshuffle comes as Amrize trades at CHF32.07, with the share price down 15.3% over the past month and 28.5% over the last quarter, while the 1-year total shareholder return has declined 23.4%, a pattern that points to fading momentum as investors reassess...

Novartis reported Phase III REMODEL-1/-2 data showing that remibrutinib reduced annualized relapse rates and MRI lesions versus teriflunomide in adults with relapsing multiple sclerosis, with a favorable safety profile and plans to seek global regulatory approval. The remibrutinib readout adds another late-stage asset alongside existing priority brands and reinforces Novartis' focus on high-value immunology and neuroscience therapies that can support its broader push for higher quality...

Medacta Group reported half year 2026 sales of €368.17 million and net income of €41.86 million, while also issuing full year guidance targeting 10% to 14% revenue growth in constant currency. The mix of higher sales and lower earnings, combined with explicit revenue growth targets, highlights how Medacta Group is balancing expansion with profitability pressures. We will now assess how Medacta Group's investment narrative could shift in light of its new 10% to 14% constant currency revenue...

Amidst escalating geopolitical tensions and rising inflation concerns, European markets have recently faced headwinds, with the STOXX Europe 600 Index declining as energy prices surged. In such a challenging environment, growth companies with significant insider ownership can offer potential resilience and alignment of interests between management and shareholders.

Ypsomed Holding (SWX:YPSN) has drawn fresh attention after announcing its first US advanced manufacturing facility in Holly Springs, North Carolina, a project tied directly to its self injection systems expansion. Recent trading has been choppy. The 7 day share price return is down 8.16% and the 30 day move is down 13.45%, even though the year to date share price return is 9.09% and the 5 year total shareholder return is 152.39%. This shows that longer term momentum remains intact as...

Dätwyler Holding AG ( VTX:DAE ), is not the largest company out there, but it received a lot of attention from a...

Trade routes are being redrawn as BRICS countries push new supply chains, payment rails, and material corridors, and that ripple runs straight through the custody banks and FX specialists that keep money and securities moving. Investors watching those plumbing changes risk missing the story if they only track headlines. This article breaks down three stocks from our Global Custody Banks and FX/Risk-Management Providers screener that appear closely tied to these shifts, and explains how their...

Alcon stock reacts to UNITY M surgical microscope launch Alcon (SWX:ALC) just moved its UNITY platform forward with the commercial launch of UNITY M, a premium ophthalmic surgical microscope now rolling out in the U.S., Japan and other key markets. That product push comes as Alcon’s share price has been under pressure, with the stock at CHF55.0 and a 30-day share price return of down 9.36%. The 90-day share price return is up 4.72% and the 1-year total shareholder return is down 10.89%,...

In September 2026, European markets are navigating increased inflation concerns and rising bond yields, driven by geopolitical tensions and energy price surges. Amid this backdrop, growth companies with high insider ownership can offer a unique perspective on potential resilience and alignment of interests between management and shareholders.

Logitech International recently unveiled the MX Keypad for developers, a customizable AI-focused control center with GitHub Copilot, Claude Code, and OpenAI Codex integrations, plus three free months of GitHub Copilot Pro+ and a sustainability-focused design priced at $99.99/€99.99. The MX Keypad pushes Logitech International deeper into software-enabled peripherals by tying physical devices to AI agents, SDK-driven extensions, and a large existing installed base of compatible hardware. We...

Roche Holding (SWX:ROP) collaborator MediLink reported positive Phase III results for Tam-Peli in relapsed small-cell lung cancer. The Tam-Peli trial showed significant gains in overall survival and response rates for patients who had already relapsed after prior therapy. Genentech, Roche’s US biotech unit, received FDA Priority Review for Enspryng to treat MOGAD, a rare autoimmune disease with no approved therapies. The Tam-Peli Phase III success and Enspryng Priority Review sit alongside...

Medacta Group SA ( VTX:MOVE ) shareholders are probably feeling a little disappointed, since its shares fell 9.8% to...